Pharmerging Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Pharmerging Market
Pharmerging Market: By Geography (Tier I Countries (China), Tier II Countries (Brazil, India, Russia), Tier III Countries(Poland, Argentina, Turkey, Mexico, Venezuela, South Africa, Algeria, Pakistan, Nigeria, Ukraine)) & Geography - Forecast(2018 - 2023)
Report Code : HCR 0310
Updated Date: 31 May, 2018  

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. Pharmerging Market – Market Overview
2. Executive Summary
3. Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Pharmerging Market– Market Forces
   4.1. Drivers
      4.1.1. Rising in public and private healthcare insurance
      4.1.2. Growing global pharmaceutical market
   4.2. Restraints
      4.2.1. Higher cost of research and development
   4.3. Opportunities
      4.3.1. Emerging economies
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Pharmerging Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Pharmerging Market, By Geography
   6.1. Tier I Countries (China)
   6.2. Tier II Countries (Brazil, India, and Russia)
   6.3. Tier III Countries (Poland, Argentina, Turkey, Mexico, Venezuela, Romania, Saudi Arabia, Colombia, Vietnam, South Africa, Algeria, Thailand, Indonesia, Egypt, Pakistan, Nigeria, and Ukraine)
7. Pharmerging – Market Entropy
   7.1. Expansion
   7.2. Technological Developments
   7.3. Merger & Acquisitions, and Joint Ventures
   7.4. Supply- Contract
8. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   8.1. Merck & Co Inc.
   8.2. Novartis International AG
   8.3. Bristol-Myers Squibb Co
   8.4. Boehringer Ingelheim Pharmaceuticals Corporation
   8.5. Eli Lilly and Co.
   8.6. Bayer HealthCare AG
   8.7. AstraZeneca plc
   8.8. Sanofi S.A.
   8.9. Pfizer Inc.
   8.10. Novo Nordisk A/S.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
9. Appendix

   9.1. Abbreviations
   9.2. Sources
   9.3. Research Methodology
   9.4. Bibliography
   9.5. Compilation of Expert Insights
   9.6. Disclaimer
Globally, growing global pharmaceutical market, rise in public and private healthcare insurance, rise in collaboration, and mergers and acquisitions among multinationals rise in the awareness among people regarding pharmerging, and increasing government initiative across the globe, are the prime growth drivers of global pharmerging market. In addition, increase in adoption of pharmerging in emerging economies such as China, India and others, will create new opportunities for global pharmerging market. However, higher cost of the research and development, and complex government approval process, are the key restraints for global pharmerging market.

 Pharmerging Market

Geographically, pharmerging markets
are defined as those countries having a per capita GDP threshold of USD 25,000 and more than USD one billion spending growth from 2012 to 2016.  Thus, the pharmerging markets includes 21 countries which are further categorized in Tier I, Tier II, Tier III countries based on the IMS defined parameters and the macroeconomic factors and respective pharmaceutical market forecasts. Tier I countries which includes China, dominated global pharmerging market because of higher Chinese government’s healthcare spending. However, Tier II countries which includes India, Brazil and Russia are project to grow significantly, owing to rapidly increasing aging population, rise in consumer awareness, favourable government policies, and modernization of healthcare infrastructure in this countries. The presence of numerous small and large vendors has made the pharmerging markets highly fragmented. Challenges such as price pressure, regulatory constraints, and competition from local and other international pharmaceutical companies are faced by most of the international pharmaceutical companies. Majority of pharmaceuticals giants are focusing on technological innovations, product extensions, and inorganic growth through mergers and acquisitions, which would intensify the market in near future.

This report identifies the global pharmerging market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global pharmerging market.

This report segments global pharmerging market on the basis of geography market as follows:
  • This report has been segmented into major geography market of pharmerging, such as: Tier I Countries (China), Tier II Countries (Brazil, India, and Russia), and Tier III Countries (Poland, Argentina, Turkey, Mexico, Venezuela, Romania, Saudi Arabia, Colombia, Vietnam, South Africa, Algeria, Thailand, Indonesia, Egypt, Pakistan, Nigeria, and Ukraine)

This report identifies all the major companies operating in the pharmerging market. Some of the major companies’ profiles in detail are as follows:
  • Merck & Co Inc.
  • Novartis International AG
  • Bristol-Myers Squibb Co
  • Boehringer Ingelheim Pharmaceuticals Corporation
  • Eli Lilly and Co.
List of Tables:

Table 1: Pharmerging Market Overview 2017-2023
Table 2: Pharmerging Market Leader Analysis 2017-2018 (US$)
Table 3: Pharmerging Market Product Analysis 2017-2018 (US$)
Table 4: Pharmerging Market End User Analysis 2017-2018 (US$)
Table 5: Pharmerging Market Patent Analysis 2013-2018* (US$)
Table 6: Pharmerging Market Financial Analysis 2017-2018 (US$)
Table 7: Pharmerging Market Driver Analysis 2017-2018 (US$)
Table 8: Pharmerging Market Challenges Analysis 2017-2018 (US$)
Table 9: Pharmerging Market Constraint Analysis 2017-2018 (US$)
Table 10: Pharmerging Market Supplier Bargaining Power Analysis 2017-2018 (US$)
Table 11: Pharmerging Market Buyer Bargaining Power Analysis 2017-2018 (US$)
Table 12: Pharmerging Market Threat of Substitutes Analysis 2017-2018 (US$)
Table 13: Pharmerging Market Threat of New Entrants Analysis 2017-2018 (US$)
Table 14: Pharmerging Market Degree of Competition Analysis 2017-2018 (US$)
Table 15: Pharmerging Market Value Chain Analysis 2017-2018 (US$)
Table 16: Pharmerging Market Pricing Analysis 2018-2023 (US$)
Table 17: Pharmerging Market Opportunities Analysis 2018-2023 (US$)
Table 18: Pharmerging Market Product Life Cycle Analysis 2018-2023 (US$)
Table 19: Pharmerging Market Supplier Analysis 2017-2018 (US$)
Table 20: Pharmerging Market Distributor Analysis 2017-2018 (US$)
Table 21: Pharmerging Market Trend Analysis 2017-2018 (US$)
Table 22: Pharmerging Market Size 2017 (US$)
Table 23: Pharmerging Market Forecast Analysis 2018-2023 (US$)
Table 24: Pharmerging Market Sales Forecast Analysis 2018-2023 (Units)
Table 25: Top Companies 2017 (US$) Pharmerging Market, Revenue & Volume
Table 26: Product Launch 2017-2018 Pharmerging Market, Revenue & Volume
Table 27: Mergers & Acquistions 2017-2018 Pharmerging Market, Revenue & Volume


List of Figures:

Figure 1: Overview of Pharmerging Market 2017-2023
Figure 2: Market Share Analysis for Pharmerging Market 2017 (US$)
Figure 3: Product Comparison in Pharmerging Market 2017-2018 (US$)
Figure 4: End User Profile for Pharmerging Market 2017-2018 (US$)
Figure 5: Patent Application and Grant in Pharmerging Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Pharmerging Market 2017-2018 (US$)
Figure 7: Market Entry Strategy in Pharmerging Market 2017-2018
Figure 8: Ecosystem Analysis in Pharmerging Market 2017
Figure 9: Average Selling Price in Pharmerging Market 2017-2023
Figure 10: Top Opportunites in Pharmerging Market 2017-2018
Figure 11: Market Life Cycle Analysis in Pharmerging Market Market Life Cycle Analysis in 3D Printing
Figure 12: Global Pharmerging Market - By Geography
Figure 13: Global Pharmerging Market Value & Volume, By Geography, 2018-2023 ($) 
Figure 14: Global Pharmerging Market CAGR, By Geography, 2018-2023 (%)
Figure 15: North America Pharmerging Market Value & Volume, 2018-2023 ($)
Figure 16: US Pharmerging Market Value & Volume, 2018-2023 ($)
Figure 17: US GDP and Population, 2017-2018 ($)
Figure 18: US GDP – Composition of 2017, By Sector of Origin
Figure 19: US Export and Import Value & Volume, 2017-2018 ($)
Figure 20: Canada Pharmerging Market Value & Volume, 2018-2023 ($)
Figure 21: Canada GDP and Population, 2017-2018 ($)
Figure 22: Canada GDP – Composition of 2017, By Sector of Origin
Figure 23: Canada Export and Import Value & Volume, 2017-2018 ($)
Figure 24: Mexico Pharmerging Market Value & Volume, 2018-2023 ($)
Figure 25: Mexico GDP and Population, 2017-2018 ($)
Figure 26: Mexico GDP – Composition of 2017, By Sector of Origin
Figure 27: Mexico Export and Import Value & Volume, 2017-2018 ($)
Figure 28: South America Pharmerging Market South America 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 29: Brazil Pharmerging Market Value & Volume, 2018-2023 ($)
Figure 30: Brazil GDP and Population, 2017-2018 ($)
Figure 31: Brazil GDP – Composition of 2017, By Sector of Origin
Figure 32: Brazil Export and Import Value & Volume, 2017-2018 ($)
Figure 33: Venezuela Pharmerging Market Value & Volume, 2018-2023 ($)
Figure 34: Venezuela GDP and Population, 2017-2018 ($)
Figure 35: Venezuela GDP – Composition of 2017, By Sector of Origin
Figure 36: Venezuela Export and Import Value & Volume, 2017-2018 ($)
Figure 37: Argentina Pharmerging Market Value & Volume, 2018-2023 ($)
Figure 38: Argentina GDP and Population, 2017-2018 ($)
Figure 39: Argentina GDP – Composition of 2017, By Sector of Origin
Figure 40: Argentina Export and Import Value & Volume, 2017-2018 ($)
Figure 41: Ecuador Pharmerging Market Value & Volume, 2018-2023 ($)
Figure 42: Ecuador GDP and Population, 2017-2018 ($)
Figure 43: Ecuador GDP – Composition of 2017, By Sector of Origin
Figure 44: Ecuador Export and Import Value & Volume, 2017-2018 ($)
Figure 45: Peru Pharmerging Market Value & Volume, 2018-2023 ($)
Figure 46: Peru GDP and Population, 2017-2018 ($)
Figure 47: Peru GDP – Composition of 2017, By Sector of Origin
Figure 48: Peru Export and Import Value & Volume, 2017-2018 ($)
Figure 49: Colombia Pharmerging Market Value & Volume, 2018-2023 ($)
Figure 50: Colombia GDP and Population, 2017-2018 ($)
Figure 51: Colombia GDP – Composition of 2017, By Sector of Origin
Figure 52: Colombia Export and Import Value & Volume, 2017-2018 ($)
Figure 53: Costa Rica Pharmerging Market Costa Rica 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 54: Costa Rica GDP and Population, 2017-2018 ($)
Figure 55: Costa Rica GDP – Composition of 2017, By Sector of Origin
Figure 56: Costa Rica Export and Import Value & Volume, 2017-2018 ($)
Figure 57: Europe Pharmerging Market Value & Volume, 2018-2023 ($)
Figure 58: U.K Pharmerging Market Value & Volume, 2018-2023 ($)
Figure 59: U.K GDP and Population, 2017-2018 ($)
Figure 60: U.K GDP – Composition of 2017, By Sector of Origin
Figure 61: U.K Export and Import Value & Volume, 2017-2018 ($)
Figure 62: Germany Pharmerging Market Value & Volume, 2018-2023 ($)
Figure 63: Germany GDP and Population, 2017-2018 ($)
Figure 64: Germany GDP – Composition of 2017, By Sector of Origin
Figure 65: Germany Export and Import Value & Volume, 2017-2018 ($)
Figure 66: Italy Pharmerging Market Value & Volume, 2018-2023 ($)
Figure 67: Italy GDP and Population, 2017-2018 ($)
Figure 68: Italy GDP – Composition of 2017, By Sector of Origin
Figure 69: Italy Export and Import Value & Volume, 2017-2018 ($)
Figure 70: France Pharmerging Market Value & Volume, 2018-2023 ($)
Figure 71: France GDP and Population, 2017-2018 ($)
Figure 72: France GDP – Composition of 2017, By Sector of Origin
Figure 73: France Export and Import Value & Volume, 2017-2018 ($)
Figure 74: Netherlands Pharmerging Market Value & Volume, 2018-2023 ($)
Figure 75: Netherlands GDP and Population, 2017-2018 ($)
Figure 76: Netherlands GDP – Composition of 2017, By Sector of Origin
Figure 77: Netherlands Export and Import Value & Volume, 2017-2018 ($)
Figure 78: Belgium Pharmerging Market Value & Volume, 2018-2023 ($)
Figure 79: Belgium GDP and Population, 2017-2018 ($)
Figure 80: Belgium GDP – Composition of 2017, By Sector of Origin
Figure 81: Belgium Export and Import Value & Volume, 2017-2018 ($)
Figure 82: Spain Pharmerging Market Value & Volume, 2018-2023 ($)
Figure 83: Spain GDP and Population, 2017-2018 ($)
Figure 84: Spain GDP – Composition of 2017, By Sector of Origin
Figure 85: Spain Export and Import Value & Volume, 2017-2018 ($)
Figure 86: Denmark Pharmerging Market Value & Volume, 2018-2023 ($)
Figure 87: Denmark GDP and Population, 2017-2018 ($)
Figure 88: Denmark GDP – Composition of 2017, By Sector of Origin
Figure 89: Denmark Export and Import Value & Volume, 2017-2018 ($)
Figure 90: APAC Pharmerging Market Value & Volume, 2018-2023 ($)
Figure 91: China Pharmerging Market Value & Volume, 2018-2023
Figure 92: China GDP and Population, 2017-2018 ($)
Figure 93: China GDP – Composition of 2017, By Sector of Origin
Figure 94: China Export and Import Value & Volume, 2017-2018 ($) Pharmerging Market China Export and Import Value & Volume, 2017-2018 ($)
Figure 95: Australia Pharmerging Market Value & Volume, 2018-2023 ($)
Figure 96: Australia GDP and Population, 2017-2018 ($)
Figure 97: Australia GDP – Composition of 2017, By Sector of Origin
Figure 98: Australia Export and Import Value & Volume, 2017-2018 ($)
Figure 99: South Korea Pharmerging Market Value & Volume, 2018-2023 ($)
Figure 100: South Korea GDP and Population, 2017-2018 ($)
Figure 101: South Korea GDP – Composition of 2017, By Sector of Origin
Figure 102: South Korea Export and Import Value & Volume, 2017-2018 ($)
Figure 103: India Pharmerging Market Value & Volume, 2018-2023 ($)
Figure 104: India GDP and Population, 2017-2018 ($)
Figure 105: India GDP – Composition of 2017, By Sector of Origin
Figure 106: India Export and Import Value & Volume, 2017-2018 ($)
Figure 107: Taiwan Pharmerging Market Taiwan 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 108: Taiwan GDP and Population, 2017-2018 ($)
Figure 109: Taiwan GDP – Composition of 2017, By Sector of Origin
Figure 110: Taiwan Export and Import Value & Volume, 2017-2018 ($)
Figure 111: Malaysia Pharmerging Market Malaysia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 112: Malaysia GDP and Population, 2017-2018 ($)
Figure 113: Malaysia GDP – Composition of 2017, By Sector of Origin
Figure 114: Malaysia Export and Import Value & Volume, 2017-2018 ($)
Figure 115: Hong Kong Pharmerging Market Hong Kong 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 116: Hong Kong GDP and Population, 2017-2018 ($)
Figure 117: Hong Kong GDP – Composition of 2017, By Sector of Origin
Figure 118: Hong Kong Export and Import Value & Volume, 2017-2018 ($)
Figure 119: Middle East & Africa Pharmerging Market Middle East & Africa 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 120: Russia Pharmerging Market Russia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 121: Russia GDP and Population, 2017-2018 ($)
Figure 122: Russia GDP – Composition of 2017, By Sector of Origin
Figure 123: Russia Export and Import Value & Volume, 2017-2018 ($)
Figure 124: Israel Pharmerging Market Value & Volume, 2018-2023 ($)
Figure 125: Israel GDP and Population, 2017-2018 ($)
Figure 126: Israel GDP – Composition of 2017, By Sector of Origin
Figure 127: Israel Export and Import Value & Volume, 2017-2018 ($)
Figure 128: Entropy Share, By Strategies, 2017-2018* (%) Pharmerging Market
Figure 129: Developments, 2017-2018* Pharmerging Market
Figure 130: Company 1 Pharmerging Market Net Revenue, By Years, 2017-2018* ($)
Figure 131: Company 1 Pharmerging Market Net Revenue Share, By Business segments, 2017 (%)
Figure 132: Company 1 Pharmerging Market Net Sales Share, By Geography, 2017 (%)
Figure 133: Company 2 Pharmerging Market Net Revenue, By Years, 2017-2018* ($)
Figure 134: Company 2 Pharmerging Market Net Revenue Share, By Business segments, 2017 (%)
Figure 135: Company 2 Pharmerging Market Net Sales Share, By Geography, 2017 (%)
Figure 136: Company 3 Pharmerging Market Net Revenue, By Years, 2017-2018* ($)
Figure 137: Company 3 Pharmerging Market Net Revenue Share, By Business segments, 2017 (%)
Figure 138: Company 3 Pharmerging Market Net Sales Share, By Geography, 2017 (%)
Figure 139: Company 4 Pharmerging Market Net Revenue, By Years, 2017-2018* ($)
Figure 140: Company 4 Pharmerging Market Net Revenue Share, By Business segments, 2017 (%)
Figure 141: Company 4 Pharmerging Market Net Sales Share, By Geography, 2017 (%)
Figure 142: Company 5 Pharmerging Market Net Revenue, By Years, 2017-2018* ($)
Figure 143: Company 5 Pharmerging Market Net Revenue Share, By Business segments, 2017 (%)
Figure 144: Company 5 Pharmerging Market Net Sales Share, By Geography, 2017 (%)
Figure 145: Company 6 Pharmerging Market Net Revenue, By Years, 2017-2018* ($)
Figure 146: Company 6 Pharmerging Market Net Revenue Share, By Business segments, 2017 (%)
Figure 147: Company 6 Pharmerging Market Net Sales Share, By Geography, 2017 (%)
Figure 148: Company 7 Pharmerging Market Net Revenue, By Years, 2017-2018* ($)
Figure 149: Company 7 Pharmerging Market Net Revenue Share, By Business segments, 2017 (%)
Figure 150: Company 7 Pharmerging Market Net Sales Share, By Geography, 2017 (%)
Figure 151: Company 8 Pharmerging Market Net Revenue, By Years, 2017-2018* ($)
Figure 152: Company 8 Pharmerging Market Net Revenue Share, By Business segments, 2017 (%)
Figure 153: Company 8 Pharmerging Market Net Sales Share, By Geography, 2017 (%)
Figure 154: Company 9 Pharmerging Market Net Revenue, By Years, 2017-2018* ($)
Figure 155: Company 9 Pharmerging Market Net Revenue Share, By Business segments, 2017 (%)
Figure 156: Company 9 Pharmerging Market Net Sales Share, By Geography, 2017 (%)
Figure 157: Company 10 Pharmerging Market Net Revenue, By Years, 2017-2018* ($)
Figure 158: Company 10 Pharmerging Market Net Revenue Share, By Business segments, 2017 (%)
Figure 159: Company 10 Pharmerging Market Net Sales Share, By Geography, 2017 (%)
Figure 160: Company 11 Pharmerging Market Net Revenue, By Years, 2017-2018* ($)
Figure 161: Company 11 Pharmerging Market Net Revenue Share, By Business segments, 2017 (%)
Figure 162: Company 11 Pharmerging Market Net Sales Share, By Geography, 2017 (%)
Figure 163: Company 12 Pharmerging Market Net Revenue, By Years, 2017-2018* ($)
Figure 164: Company 12 Pharmerging Market Net Revenue Share, By Business segments, 2017 (%)
Figure 165: Company 12 Pharmerging Market Net Sales Share, By Geography, 2017 (%)
Figure 166: Company 13 Pharmerging Market Net Revenue, By Years, 2017-2018* ($)
Figure 167: Company 13 Pharmerging Market Net Revenue Share, By Business segments, 2017 (%)
Figure 168: Company 13 Pharmerging Market Net Sales Share, By Geography, 2017 (%)
Figure 169: Company 14 Pharmerging Market Net Revenue, By Years, 2017-2018* ($)
Figure 170: Company 14 Pharmerging Market Net Revenue Share, By Business segments, 2017 (%)
Figure 171: Company 14 Pharmerging Market Net Sales Share, By Geography, 2017 (%)
Figure 172: Company 15 Pharmerging Market Net Revenue, By Years, 2017-2018* ($)
Figure 173: Company 15 Pharmerging Market Net Revenue Share, By Business segments, 2017 (%)
Figure 174: Company 15 Pharmerging Market Net Sales Share, By Geography, 2017 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll